drugset / Trial / NCT04264000

Platelet-rich Plasma Injection for Ulnar Neuropathy at Elbow

NCT04264000

Completed 30 enrolled Yung-Tsan Wu
RandomizedParallel-groupDouble-blindTreatment

Summary

Ulnar neuropathy at elbow (UNE) is the second common peripheral entrapment neuropathy after carpal tunnel syndrome (CTS). Although many conservative managements of UNE were found, their effectiveness were often unsatisfied without existed guideline. Recently, the perineural injection of 5% dextrose wate (D5W) is a novel management for CTS but its effect for UNE is not obviously as CTS. Hence, it is very important to find another novel injectate for UNE.

Timeline

Start
2020-08-01
Primary completion
2024-03-31
Completion
2024-03-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dextrose Unknown 3 ml Other
Comparator Dextrose Unknown 5 % Other
Subject Platelet Rich Plasma Other / unclassified 3 ml Other

Indications